Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02990377 · ClinicalTrials.gov registry record · NA
Reducing Non-Medical Opioid Use: An Automatically Adaptive mHealth Intervention
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 459
- Enrollment target
NCT02990377: Completed NA study, sponsored by University of Michigan.
NCT02990377 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 459 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02990377, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 459 participants
- Enrollment target
Study Summary
In recent years in the U.S., problems associated with opioid prescriptions, including non-medical use and overdose, increased to historically unprecedented levels and represent a public health crisis. Emergency departments (EDs) play an important role in opioid prescribing, particularly to individuals at high risk for adverse opioid-related outcomes. The purpose of this study is to determine whether a new mobile health (mhealth) intervention can assist people in the safe use of opioid analgesic (OA) medications after leaving the emergency department (ED). The specific aims of this project are to: (1) adapt and enhance an existing motivational intervention to decrease non-medical opioid use after an ED visit by optimizing intervention intensity and duration through reinforcement learning (RL); (2) examine the impact of an RL-supported intervention on non-medical opioid use level during the six months post-ED visit; and (3) examine the impact of the RL intervention on the opioid-related behaviors and adverse outcomes of driving after opioid use, overdose risk behaviors, and subsequent opioid-related ED visits. The secondary aims of this project are to: (SA1) examine whether baseline level of non-medical opioid use moderates the effects of the intervention; and (SA2) understand barriers and facilitators of implementation of the intervention based on qualitative interviews with ED patients.
Primary Outcome
The Current Opioid Misuse Measure (COMM) assesses opioid use that is more than prescribed, for non-pain-related reasons, borrowing medications, obtaining medications from sources other than doctors, etc., on a 5-point Likert scale of "Never" to "Very Often." The primary outcome will be a measure of severity created by summing the items.
Interventions
- BEHAVIORAL RL-supported IVR intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 459 participants |
| Start Date | 2018-11-06 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
What the finished NCT02990377 record still lists
NCT02990377 is an interventional study that assigns participants to a tested intervention. The registered 459 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 1 intervention - of which RL-supported IVR intervention is the first listed.
NCT02990377 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02990377 about?
NCT02990377 is a clinical study titled "Reducing Non-Medical Opioid Use: An Automatically Adaptive mHealth Intervention". In recent years in the U.S., problems associated with opioid prescriptions, including non-medical use and overdose, increased to historically unprecedented levels and represent a public health crisis. Emergency departments (EDs) play an important role in opioid prescribing, particularly to individua...
What is the current status of trial NCT02990377?
This trial is currently completed. It is a NA study. The enrollment target is 459 participants. The study started on 2018-11-06. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT02990377?
The interventions under investigation include: RL-supported IVR intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02990377?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02990377's enrollment target sits among peer trials
459 224th of 2000 higher than 1,777 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04452825 · 459 participants · NA
A New Psychotherapy Intervention for Older Cancer Patients
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI